Navigation Links
Mass. General Cancer Center and Vall d'Hebron Institute of Oncology biomarker alliance
Date:11/16/2011

equally between the two centers, with MGHCC matching the BBVA Foundation's contribution. Both institutions are committed to sharing and exchanging findings and will place their biomarker platforms in genomics, proteomics and molecular pathology at the disposal of the new program.

The agreement also includes an express undertaking by the parties to share their results with the rest of the scientific community and, by this means, hasten their availability to cancer patients.

"We are grateful as well as strongly impressed that the BBVA Foundation is not only maintaining but enlarging its support for this program, along with its broader commitment to research in general, and cancer research in particular, at a time of economic difficulties," declared Dr. Baselga.

The BBVA Foundation President was quick to concur, while adding: "Spain cannot afford to slip behind in an area where it has already attained a position of some prominence, and where research results can drive tangible improvements in the diagnostic and therapeutic options available to patients."

In today's climate of austerity, Francisco Gonzlez stressed the need to "preserve the core elements of an economy like Spain's which has no other route map but knowledge and innovation." In the case of the BBVA Foundation, this translates as "a multipronged program of support for research and the creation of knowledge-driven public goods, with a focus on areas, like health and environmental conservation, in the foreground of citizens' preferences and expectations." On the topic of the BBVA Foundation Tumor Biomarkers Research Program, he explained that "the international cooperation model underlying this program is not a novelty for the BBVA Foundation, but rather reflects our conviction that the best research is currently being done in cross-border networks involving hubs of excellence."

The "signature" of cancer

Biomarkers are a mainstay of today's cancer
'/>"/>

Contact: BBVA Foundation Communication Department
comunicacion@fbbva.es
34-913-745-210
Vall dHebron Institute of Oncology
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Uninsured patients in Mass. still mainly the working poor, despite states health reform
2. Mass. General team identifies new class of antiangiogenesis drugs
3. Mass. General study reveals how lung cancers evolve in response to targeted treatment
4. Mass. Health Reform Hasnt Halted Medical Bankruptcies
5. Mass. General enters collaboration to develop new approach to capturing circulating tumor cells
6. Mass. doctor invents product to curb hospital-acquired infections
7. Researchers to study effects of Mass. health reform
8. Mass. General Hospital, Iacocca Foundation announce completion of Phase I diabetes trial
9. Mass. Eye and Ear receives NEI grant renewal for growing clinical/scientists
10. Mass. General Hospital to create registry for coronary optical coherence tomography
11. Novel, noninvasive measurement a strong predictor for heart failure in general population
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Losing Weight Your Body’s Way , In a world ... face, it certainly can be difficult to choose the right ... favor by doing it the healthy way? Set aside the ... your body, exercise regularly, and choose foods with the most ... you need to exercise more and eat less. Despite the ...
(Date:10/22/2014)... By Steven Reinberg ... -- Infants who quickly add weight and length may be ... study suggests. In adults, certain genes have been linked ... promote proportionate gains in fat and lean muscle, the researchers ... be heavier and taller. By ages 2 and 3, however, ...
(Date:10/22/2014)... News) -- Measures taken by Firestone officials at the ... have limited the spread of the disease there and ... Natural Rubber Co. provides health services to about 80,000 ... populated communities. Between Aug. 1 and Sept. 23, ... those 80,000 people. That incidence rate of 0.09 percent ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Allegheny General ... procedure that enables physicians to repair a damaged mitral ... MitraClip system, developed by Abbott Vascular ... a progressive and life-threatening condition in which the heart’s ... to flow backward from the heart’s left ventricle into ...
(Date:10/20/2014)... October 20, 2014 hc1.com today ... secure cloud solution that enables healthcare organizations of ... ultimate healthcare-specific customer relationship management (“CRM”) solution. , ... unique needs of the healthcare industry, the hc1 ... providers and patients by combining healthcare CRM, HIPAA-compliant ...
Breaking Medicine News(10 mins):Health News:ReductionGuruMD Presents Ways to Improve Your Weight Loss Results 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2
... ... site called Muscle and Fitness Trainer has launched several new features to help its members ... a Motivate Me feature. , ... ,(PRWEB) January 27, 2010 -- Muscle and Fitness Trainer ...
... , WASHINGTON , Jan. ... the U.S. Census Bureau: , (Logo: http://www.newscom.com/cgi-bin/prnh/20090226/CENSUSLOGO ) , ... , Profile America — Wednesday, January 27th . ... the first U.S. city to treat its water supply with fluoride. ...
... , New member-led union caps first year ... grabs and secret deals with employers , LOS ANGELES ... day after SEIU seized control of California,s healthcare union ... Kaiser hospitals and clinics have voted to take back their union ...
... The following statement is attributed to Bruce Yarwood , ... Jan. 26 The American Health Care Association and National ... and strengthening the ability of our nation,s long term care sector ... base, must be twin cornerstones of the 2010 legislative agenda that ...
... Health care a basic human right, say bishops , Don,t ... follow Hyde and not pay for elective abortions , WASHINGTON , ... to work on health care reform to provide access for everyone, protection of ... January 26 letter signed by Cardinal Daniel DiNardo of ...
... SALEM, N.H. , Jan. 26 ALPCO Diagnostics ... of total proinsulin (I and II) in rats and mice.  These methods ... in bacteria and purified from inclusion bodies, and were first introduced in ... June 2009 . , Both the Rat Proinsulin ELISA and ...
Cached Medicine News:Health News:Personal Training Web Site, the Ultimate Resource for Online Fitness Training and Nutrition 2Health News:Personal Training Web Site, the Ultimate Resource for Online Fitness Training and Nutrition 3Health News:Personal Training Web Site, the Ultimate Resource for Online Fitness Training and Nutrition 4Health News:U.S. Census Bureau Daily Feature for Jan. 27 2Health News:Kaiser Workers Vote to Join NUHW, Reject SEIU in Three Elections 2Health News:Kaiser Workers Vote to Join NUHW, Reject SEIU in Three Elections 3Health News:Statement From the American Health Care Association and National Center for Assisted Living in Anticipation of President Obama's State of the Union Address 2Health News:Bishops Urge Congress to Resume Work on Health Care With Access for All, Protection of Life, Conscience Rights 2Health News:Bishops Urge Congress to Resume Work on Health Care With Access for All, Protection of Life, Conscience Rights 3Health News:ALPCO Announces the Launch of Rat and Mouse Proinsulin ELISA Kits 2Health News:ALPCO Announces the Launch of Rat and Mouse Proinsulin ELISA Kits 3
(Date:10/22/2014)... , Oct. 22, 2014 WHEN: Wednesday, ... Online, complimentary registration available at: http://bit.ly/1yStiU9 ... Archana Vidyasekar and Visionary Innovation Research Group ... wireless electricity, self-assembling materials, nanobots and flexible ... which will transform our lives in the ...
(Date:10/22/2014)... JOLLA, Calif. , Oct. 22, 2014 ... RGLS ), a biopharmaceutical company leading the ... microRNAs, today announced that it has demonstrated ... an ongoing clinical study evaluating RG-101, a ... the treatment of hepatitis C virus infection ...
(Date:10/20/2014)... , Oct. 20, 2014  Luoxis Diagnostics, ... MKT: AMPE), today announced that its academic collaborators ... and research potential for its novel RedoxSYS Diagnostic ... (ORP) in the body in response to injury ... of ORP as a clinical marker will be ...
Breaking Medicine Technology:Futuristic Technologies That Will Transform Our World Beyond 2030 2Futuristic Technologies That Will Transform Our World Beyond 2030 3Futuristic Technologies That Will Transform Our World Beyond 2030 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 2Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 3Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 4Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 5
... to Advance for Treatment of AllergySAN DIEGO , ... focused on the development of novel Toll-Like Receptor 8 ... inflammatory diseases, announced today that it has initiated a ... TLR8 agonist for the treatment of allergic rhinitis. The ...
... Percent of Newly Diagnosed Patients Receive a Drug Within ... New Report from Decision ResourcesWALTHAM, Mass., April 15 ... the world,s leading research and advisory firms focusing on ... that less than 30 percent of their use of ...
Cached Medicine Technology:VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis 2Surveyed Neurologists Anticipate That Less Than 30 Percent of Their Use of Emerging Oral Agents in Multiple Sclerosis Will be in the First Line 2Surveyed Neurologists Anticipate That Less Than 30 Percent of Their Use of Emerging Oral Agents in Multiple Sclerosis Will be in the First Line 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: